Format

Send to

Choose Destination
See comment in PubMed Commons below
JAMA Dermatol. 2014 Aug;150(8):844-9. doi: 10.1001/jamadermatol.2013.8687.

Efficacy of a needling device for the treatment of acne scars: a randomized clinical trial.

Author information

1
Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois2Department of Otolaryngology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois3Department of Surgery, Feinberg School of Medicine, No.
2
Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
3
Department of Medicine, Emory University School of Medicine, Atlanta, Georgia5Center for Research and Grants, Baptist Health South Florida, Miami.

Abstract

IMPORTANCE:

Neocollagenesis can be achieved using a dermal rolling needle device, thereby reducing the appearance of acne scars.

OBJECTIVE:

To determine the efficacy of a needling device for treatment of acne scars.

DESIGN, SETTING, AND PARTICIPANTS:

We performed a single-center, rater-blinded, balanced (1:1), split-face, placebo-controlled, parallel-group randomized clinical trial at an urban academic institution. The study took place from November 30, 2009, through July 27, 2010. Twenty healthy adults (age range, 20-65 years) with acne scars on both sides of the face were enrolled. Fifteen individuals completed the study, and no enrolled participants were withdrawn for adverse effects.

INTERVENTIONS:

For each participant, one side of the face was randomized for needling. Three needling treatments were performed at 2-week intervals.

MAIN OUTCOMES AND MEASURES:

Two blinded dermatologists separately rated participants' acne scars based on standard digital photographs obtained at baseline and at the 3-month and 6-month follow-up visits on the quantitative global scarring grading system.

RESULTS:

Mean scar scores were significantly lower in the treatment group compared with baseline at 6 months (mean difference, 3.4; 95% CI, 0.2-6.5; P = .03) and nominally but not significantly lower compared with baseline at 3 months (mean difference, 2.4; 95% CI, -0.01 to 4.8; P = .052). In the control group, mean scar scores did not vary significantly from baseline at 3 months (mean difference, 1.0; 95% CI, -1.4 to 3.4; P = .96) and at 6 months (mean difference, 0.4; 95% CI, -2.3 to 3.5; P > .99). The needling procedure was not particularly painful, with a mean pain rating of 1.08 of 10. Participants perceived a 41% mean improvement in overall scar appearance on the treated side. No adverse events were reported.

CONCLUSIONS AND RELEVANCE:

After 3 needling treatments, there was improvement in the appearance of acne scars over time compared with the control group, with minimal pain reported.

TRIAL REGISTRATION:

clinicaltrials.gov Identifier: NCT00974870.

PMID:
24919799
DOI:
10.1001/jamadermatol.2013.8687
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Support Center